- Home
- Free App Analytics
- Bugs & Drugs 2.0
- Bugs & Drugs 2.0 Vs. CDN STBBI Guidelines
Bugs & Drugs 2.0 vs CDN STBBI Guidelines Usage & Stats
We are pleased to release this new version of Bugs & Drugs.
Bugs & Drugs is a comprehensive, evidence-based reference for physicians, dentists, pharmacists, nurse practitioners and other health care practitioners.
Bugs & Drugs provides clinicians with the latest recommendations for the appropriate use of antimicrobials and the optimal treatment and prevention of infectious diseases. It is also a key component of antimicrobial stewardship efforts. This reference can optimize patient outcomes and minimize the unintended consequences of antimicrobial use, including toxicity, superinfections, resistance, and unnecessary treatment costs.
Bugs & Drugs is divided into six sections:
1. Antibiotics
2. Treatment recommendations for infections in children and adults (including selected ophthalmic, fungal, and parasitic infections),
3. Recommendations for the prevention of infections,
4. Treatment and prophylaxis of dental infections,
5. Infections in Pregnancy and
6. Microbiology
The Bugs & Drugs app is well suited for healthcare practitioners looking for an evidence-based mobile reference and provides therapeutic options in a clear, concise manner.
Once installed, you do not need internet access to use the content. Internet access is only required for initial installation of the app and to receive updates.
The content is prepared by Dr. Edith Blondel-Hill (Medical Microbiologist/Infectious Diseases Specialist, Kelowna General Hospital) and Ms. Susan Fryters (Antimicrobial Stewardship/Infectious Diseases Pharmacist, Alberta Health Services) with the help of over 40 reviewers with expertise in infectious diseases, infection prevention & control, microbiology, pharmacy, and Public Health.
Users should seek a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Free
- Medical
Store Rank
- -
Note: This application is intended for use by HEALTH PROFESSIONALS, and not the general public. For general information on sexually transmitted infections (STIs), refer to https://www.canada.ca/en/public-health/services/diseases.html
This application provides Canadian health professionals with up-to-date recommendations for the screening, diagnosis, management, and treatment of STIs, including recommendations for antibiotic-resistant gonorrhea, in a convenient, concise, and easy to use format.
It has been developed from the 2010 version of the Canadian Guidelines on Sexually Transmitted Infections (Guidelines) (http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php) and revised content from 2013 to 2016. These updates reflect emerging issues/trends affecting the management of STIs in Canada. Up-to-date information from other complementary resources has also been incorporated, including key recommendations from the HIV Screening and Testing Guide (2012) and the Management of Hepatitis B - Quick Reference (2013).
The content is reflective of the most current evidence for the management of uncomplicated STIs in adults and youth only. It does not contain information for the management of STIs in pregnant women, children, neonates or complicated infections.
This application is intended to provide information to public health and clinical professionals and does not supersede any provincial/territorial legislative, regulatory, policy and practice requirements or professional guidelines that govern the practice of health professionals in their respective jurisdictions, whose recommendations may differ due to local epidemiology or context.
- Apple App Store
- Free
- Medical
Store Rank
- -
Bugs & Drugs 2.0 vs. CDN STBBI Guidelines ranking comparison
Compare Bugs & Drugs 2.0 ranking trend in the past 28 days vs. CDN STBBI Guidelines
Rank
No Data Available
Bugs & Drugs 2.0 vs. CDN STBBI Guidelines ranking by country comparison
Compare Bugs & Drugs 2.0 ranking trend in the past 28 days vs. CDN STBBI Guidelines
No Data to Display
Compare to any site with our free trial
Bugs & Drugs 2.0 VS.
CDN STBBI Guidelines
January 3, 2025